MeiraGTx Holdings plc (MGTX) earnings date, results and what the price requires
Nasdaq · SEC CIK 0001735438 · SEC filings checked Oct 18, 2026
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 13, 2026 | $321.4M | $160.7M | $1.71 | Filing |
| Mar 31, 2026 | May 14, 2026 | $293,000 | $-46.3M | $-0.57 | Filing |
| Dec 31, 2025 | Mar 26, 2026 | $75.4M | — | $0.19 | Filing |
| Sep 30, 2025 | Nov 13, 2025 | $410,000 | $-50.5M | $-0.62 | Filing |
| Jun 30, 2025 | Aug 14, 2025 | $3.7M | $-38.8M | $-0.48 | Filing |
| Mar 31, 2025 | May 13, 2025 | $1.9M | $-40.0M | $-0.51 | Filing |
| Dec 31, 2024 | Mar 13, 2025 | $21.4M | — | $-0.49 | Filing |
| Sep 30, 2024 | Nov 13, 2024 | $10.9M | $-39.3M | $-0.55 | Filing |
What would MeiraGTx Holdings plc have to report for its valuation to change?
At $9.28, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about 2.2% a year, to $0.79. On that path the next quarter needs diluted EPS near $-0.63, against $-0.62 in the quarter ended Sep 30, 2025.
Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.
| Result | Original | Yours |
|---|---|---|
| Required EPS growth / year | 2.2% | 2.2% |
| EPS needed in final year | $0.79 | $0.79 |
Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.
Prepare for earnings across my investments — $399/month
Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. MGTX goes in with your buy-or-wait comparison and assumptions preserved.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.